Allison Bianchi, PhD

Allison Bianchi, PhD, is Vice President of Cell Therapy Development at Bristol Myers Squibb and serves as Site Head for its Seattle hub. She leads cross-functional teams driving next-generation cell therapy programs, including both autologous and allogeneic approaches, while overseeing integration across research, development, and manufacturing. Bianchi began her career in cell therapy at Juno Therapeutics, where she led molecular assays and built a 75-person team to develop CAR-T manufacturing processes and analytics, including the NEX-T platform still used by BMS today. She also helped design BMS’ Seattle Dexter facility. Passionate about improving patient outcomes, Bianchi focuses on making cell therapies faster, more accessible, and broadly applicable beyond oncology.